Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model

Intuitive Surgical



) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day up 0.2%. By the end of trading, Intuitive Surgical rose $23.07 (4.8%) to $501.53 on heavy volume. Throughout the day, 907,562 shares of Intuitive Surgical exchanged hands as compared to its average daily volume of 507,200 shares. The stock ranged in a price between $490.71-$508.00 after having opened the day at $492.00 as compared to the previous trading day's close of $478.46. Other companies within the Health Services industry that increased today were:




), up 12.4%,




), up 12.0%,

Escalon Medical Corporation



), up 10.3% and

Thermogenesis Corporation



), up 10.0%.

  • EXCLUSIVE OFFER: Jim Cramer's Protege, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Intuitive Surgical has a market cap of $18.9 billion and is part of the health care sector. The company has a P/E ratio of 27.6, above the S&P 500 P/E ratio of 17.7. Shares are down 4.1% year to date as of the close of trading on Thursday. Currently there are 11 analysts that rate Intuitive Surgical a buy, 1 analyst rates it a sell, and 3 rate it a hold.

TheStreet Ratings rates Intuitive Surgical as a


. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself.

On the negative front,

ERBA Diagnostics



), down 10.2%,




), down 10.0%,

BSD Medical Corporation



), down 7.5% and

Medical Action Industries



), down 5.6% , were all laggards within the health services industry with




) being today's health services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider

Health Care Select Sector SPDR



) while those bearish on the health services industry could consider

ProShares Ultra Short Health Care




Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100%. See his top picks for 14-days FREE.